Director, Patient Centered Science

At AstraZeneca we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial thinking big and working together to make the impossible a reality. If you are swift to action confident to lead willing to collaborate and curious about what science can do thenyoureour kind of person.

At Patient Centered Science (PCS) our purpose is to generate impactful evidence about patient outcomes andexperiences. We have the mission toidentifymeasureunderstand and communicate meaningful patient outcomes andexperiences of their disease andtreatment with thevision isto positivelyimpactlives by amplifying the patient voice in seektoidentify understand and measure meaningful aspects of health grounded in patient experiences including symptoms function and health-related quality of life. Using qualitative and quantitative methods and research PCS supports a patient-focused drug development by identifying what is important from a patient perspective how to best capture those patient experiences by selecting modifying or developing Patient Reported Outcomes (PRO) and other Clinical Outcome Assessments (COA) to serve the needs of patients as well as regulators payers and health-care professionals.

What an extraordinary time to join AstraZenecas BioPharmaceuticals R&D Team!A place to be at the forefront we use our unique position as medical leaders across our enterprise and the healthcare ecosystem to shape the future of healthcare.Theresso much opportunity here as we continue to grow no better place to improve patients lives and develop with AstraZeneca.

As a Patient Centered Science Director you will set and lead project-level and therapeutic area-level PRO and patient experience strategies. You will direct execution of these strategies to deliver high-quality evidence supporting products regulatory approval commercialization and reimbursement. Your contributions and accountabilities will include but will not be limited to the following:

• Drive patient-focused drug development so that the patient experience of disease and treatment is considered throughout drug development and generate evidence to better meet patient needs

• Develop and deliver project and therapeutic area PCS strategies (eg understanding patient experience of disease and treatment and how to best measure with PRO/COA; contributing to target product profiles and target product claims) to meet regulatory payer health care provider/system and patient needs

• Lead evidence generation to support PRO/COAs being fit-for purpose including theselectionand modification of available PROs/COAs and the development of new PRO/COA instruments and endpoints

• Ensure PCS strategy is implemented through cross-functional collaborations in clinical trials studies through authorship and reviews of clinical study protocols statistical analysis plans psychometric analysis plans and results interpretation and reports

• Lead interactions with health authorities and health agencies through development of PRO/COA evidence dossiers and briefing packages

• Disseminate PCS-related evidence in scientific publications internal and external presentations (egposters and presentations at congresses) and in lay summaries to patients and other stakeholders

• Drive methodological innovations that advance patient-centered science through internal and external partnerships and collaboration

Minimum Qualifications:

• Mastersdegree in relevant field (outcomes research health services research epidemiology healthpolicyor relatedfields)

• 5years experiencein the biopharmaceutical industry

• Relevant experience of developing and implementing strategies of patient-centered science related work

• Experience of conducting background research landscape assessments and literature reviews and applying qualitative and quantitative research methods

• Knowledge and experience of clinical development

• Experience of cross-functional collaboration and leading without authority

Desirable Qualifications:

• Doctoral degree in relevant field preferred

• Participating in external partnership

• Experience of regulatory and health agency interactions

• Experience of working withrespiratoryandimmunologytherapies

Why AstraZeneca

At AstraZeneca we re dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. Theres no better place to make a difference to medicine patients and society. An inclusive culture that champions diversity and collaboration and always committed to lifelong learning growth and development. Were on an exciting journey to pioneer the future of healthcare.

So whats next

Are you already imagining yourself joining our team Good because we cant wait to hear from you!

The annual base pay (or hourly rate of compensation) for this position ranges from $188732.80 - $283099.20 USD Annual. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors including market location job-related knowledge skills and addition our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles) to receive a retirement contribution (hourly roles) and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program 401(k) plan; paid vacation and holidays; paid leaves; and health benefits including medical prescription drug dental and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired employee will be in an at-will position and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time including for reasons related to individual performance Company or individual department/team performance and market factors.